bioAffinity Technologies (BIAF) Research & Development (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Research & Development of $349707.0 for Q1 2026, down 4.81% year-over-year from $367386.0 in Q1 2025, and down 6.5% quarter-over-quarter from $374012.0 in Q4 2025.
bioAffinity Technologies (BIAF) Research & Development (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Research & Development for 6 consecutive years, with $349707.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development fell 4.81% year-over-year to $349707.0; the TTM figure through Mar 2026 stood at $1.4 million (down 4.83% YoY), while the FY2025 annual figure was $1.4 million, down 5.33% from the prior year.
- Research & Development fell to $349707.0 in Q1 2026 per BIAF's latest filing, from $374012.0 in the prior quarter.
- Across five years, Research & Development topped out at $432818.0 in Q4 2023 and bottomed at $248419.0 in Q2 2022.
- Historically, Research & Development has averaged $349380.9 across 5 years, with a median of $349707.0 in 2026.
- Annual changes were most pronounced in 2022 — Research & Development jumped 250.9% — and 2025, when it retreated 22.63%.
- bioAffinity Technologies' Research & Development stood at $429236.0 in 2022, then advanced by 0.83% to $432818.0 in 2023, then retreated by 9.74% to $390658.0 in 2024, then fell by 4.26% to $374012.0 in 2025, then slipped by 6.5% to $349707.0 in 2026.
- Business Quant data shows BIAF's Research & Development at $349707.0 in Q1 2026, $374012.0 in Q4 2025, and $330589.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 364.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 412.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 228.07 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 126.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 171.28 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 252.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 52.99 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | 361,575.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 361,575.00 |
| Mar 31, 2026 | 349,707.00 |
| Dec 31, 2025 | 374,012.00 |
| Sep 30, 2025 | 330,589.00 |
| Jun 30, 2025 | 311,372.00 |
| Mar 31, 2025 | 367,386.00 |
| Dec 31, 2024 | 390,658.00 |
| Sep 30, 2024 | 274,497.00 |
| Jun 30, 2024 | 402,433.00 |
| Mar 31, 2024 | 393,639.00 |
| Dec 31, 2023 | 432,818.00 |
| Sep 30, 2023 | 330,376.00 |
| Jun 30, 2023 | 335,125.00 |
| Mar 31, 2023 | 369,617.00 |
| Dec 31, 2022 | 450,612.00 |
| Sep 30, 2022 | 319,744.00 |
| Jun 30, 2022 | 248,419.00 |
| Mar 31, 2022 | 279,848.00 |
| Dec 31, 2021 | 129,802.00 |
| Sep 30, 2021 | 330,772.00 |